Related references
Note: Only part of the references are listed.Editorial: The liver as an endocrine organ: Hepatokines and ketone bodies, novel hormones to be acknowledged
Renata Risi et al.
FRONTIERS IN ENDOCRINOLOGY (2023)
Predictors of weight loss in patients with obesity treated with a Very Low-Calorie Ketogenic Diet
Ilaria Ernesti et al.
FRONTIERS IN NUTRITION (2023)
Fibroblast growth factor 21 in heart failure
William Tucker et al.
HEART FAILURE REVIEWS (2023)
Global epidemiology of cirrhosis - aetiology, trends and predictions
Daniel Q. Huang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)
The Effect of HCV Eradication after Direct-Acting Antiviral Agents on He-patic Steatosis: A Prospective Observational Study
Hanan Soliman et al.
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2022)
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)
PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection
Marialuigia Fantacuzzi et al.
BIOLOGY-BASEL (2022)
An extra virgin olive oil-enriched chocolate spread positively modulates insulin-resistance markers compared with a palm oil-enriched one in healthy young adults: A double-blind, cross-over, randomised controlled trial
Dario Tuccinardi et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2022)
Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants
Natthaya Chuaypen et al.
PLOS ONE (2022)
Associations between serum mitokine levels and outcomes in stable COPD: an observational prospective study
Carlos A. Amado et al.
SCIENTIFIC REPORTS (2022)
FGF21 and Chronic Kidney Disease
Joao Victor Salgado et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Metabolic complications of hepatitis C virus infection
Rahul Chaudhari et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
FGF21 ameliorates hepatic fibrosis by multiple mechanisms
Fanrui Meng et al.
MOLECULAR BIOLOGY REPORTS (2021)
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
HEPATOLOGY (2020)
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Sadaf G. Sepanlou et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study
Mikiko Watanabe et al.
NUTRIENTS (2020)
Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the US, 2010-2019
Sonia Wang et al.
PLOS ONE (2020)
Liver-derived FGF21 is essential for full adaptation to ketogenic diet but does not regulate glucose homeostasis
Mikiko Watanabe et al.
ENDOCRINE (2020)
Evolution and Revolution of Hepatitis C Management: From Non-A, Non-B Hepatitis Toward Global Elimination
Viktorija Basyte-Bacevice et al.
DIGESTIVE DISEASES (2020)
Approaches, Progress, and Challenges to Hepatitis C Vaccine Development
Justin R. Bailey et al.
GASTROENTEROLOGY (2019)
Fibroblast growth factor 21 in non-alcoholic fatty liver disease
Bradley Tucker et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy
T. Tada et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
EASL Recommendations on Treatment of Hepatitis C 2018
JOURNAL OF HEPATOLOGY (2018)
Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis
Astrid Ruiz-Margain et al.
LIVER TRANSPLANTATION (2018)
A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents
Ghada M. El Sagheer et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2018)
Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review
Page Axley et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2018)
Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury
Bhavna N. Desai et al.
MOLECULAR METABOLISM (2017)
FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue
Kathleen R. Markan et al.
MOLECULAR METABOLISM (2017)
Fibroblast growth factor 21 and its novel association with oxidative stress
Miguel Angel Gomez-Samano et al.
REDOX BIOLOGY (2017)
Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses
Antero Salminen et al.
AGEING RESEARCH REVIEWS (2017)
Understanding the Physiology of FGF21
Ffolliott Martin Fisher et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis
Regina Medvedev et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation
Dewei Ye et al.
SCIENTIFIC REPORTS (2016)
Expanded Classification of Hepatitis C Virus Into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource
Donald B. Smith et al.
HEPATOLOGY (2014)
Fibroblast Growth Factor 21 Protects Against Acetaminophen-Induced Hepatotoxicity by Potentiating Peroxisome Proliferator-Activated Receptor Coactivator Protein-1α-Mediated Antioxidant Capacity in Mice
Dewei Ye et al.
HEPATOLOGY (2014)
Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases
Francesco Negro
JOURNAL OF HEPATOLOGY (2014)
Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress
Chaofeng Yang et al.
BMC GASTROENTEROLOGY (2013)
APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B
Fatma Ucar et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Serum FGF21 and RBP4 levels in patients with chronic hepatitis C
Michal Kukla et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Alteration of Hepatic Nuclear Receptor-Mediated Signaling Pathways in Hepatitis C Virus Patients With and Without a History of Alcohol Drinking
Chuanghong Wu et al.
HEPATOLOGY (2011)
A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation
Waqar Ahmad et al.
VIROLOGY JOURNAL (2011)
Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Jody Dushay et al.
GASTROENTEROLOGY (2010)
Peroxisome Proliferator-Activated Receptors in HCV-Related Infection
Sebastien Dharancy et al.
PPAR RESEARCH (2009)
Peroxisome proliferator-activated receptor-alpha and -gamma rnRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection
A De Gottardi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection
S Dharancy et al.
GASTROENTEROLOGY (2005)